Depression In Breast Cancer Patients Linked To Lack Of Estrogen
Unregistered User
If this is not your name, click here.
Contact Us | Order Now | Journals | Bookstore | Register a colleague
 
  SEARCH  
News
Bookstore
Medline
The Web
Meetings & Congresses
Complete Doctor's Guide
 


 EXPLORE :
 news  All News
 webcasts All Webcasts
 All cases All Cases
 Meetings All Meetings & Congresses
 Medical All Medical Resources

top





New drugs / indications

English Dictionary

Medical Dictionary

Thesaurus



Warning | Privacy | Awards



 Favourite Journals 

Click here to choose your favourite journals


 Favourite Sites 

Click here to choose your favourite sites


 Languages 



  




Depression In Breast Cancer Patients Linked To Lack Of Estrogen

WASHINGTON, DC -- June 29, 1999 -- Breast cancer patients may face an increased risk of depression as a result of treatment that disrupts their bodies' supplies of estrogen, according to the results of a pilot study conducted at Massachusetts General Hospital, Boston.

"Dysphoria, insomnia and hot flashes were almost universal in women whose breast cancer treatment induced estrogen deficiency," said Donna Greenberg, M.D., one of the authors of the study. "The rather abrupt change in estrogen adds to other adverse side effects of adjuvant chemotherapy and presents another difficulty for these patients."

The researchers, led by Laura Sheingold Duffy, M.D., selected 21 breast cancer patients likely to develop estrogen deficiency. The scientists conducted interviews regularly for an average of 18 months after beginning treatment with chemotherapy and/or tamoxifen. Eight women (38 percent) developed major depression, most in the first six months of treatment.

The patients included 15 women who had not yet experienced menopause at the time of diagnosis, 14 of whom showed signs of estrogen deficiency, developing hot flashes or no longer menstruating. Four of these patients became depressed.

Among the six post-menopausal women, four became depressed and of these two had stopped taking estrogen replacement therapy at the time of diagnosis.

Three of the eight patients with depression recovered fully after treatment with antidepressant medication; one treated with a low dose of antidepressant medication improved partially. One improved with psychotherapy and two with no treatment. One patient's depression did not improve over the 11 months she was followed, but she did choose not to seek treatment for depression.

"Major depressive disorder, once identified, may be responsive to therapeutic psychopharmacologic treatment, despite the lack of estrogen," Greenberg said. "Even in those patients who did not develop major depressive disorder, the clinician's attention to and clarification of menopausal symptoms seemed to be an important therapeutic strategy."

The results of the study appear in the July-August issue of Psychosomatics.

E-mail this page
to a friend or colleague!
To print,
use this version




Any question regarding a medical diagnosis, treatment, referral, drug availability or pricing should be directed to either a licensed physician or to the product's manufacturer.

If you have any technical questions or other concerns about this site, feel free to contact us at webmaster@docguide.com.

All contents Copyright (c) 1995- Doctor's Guide Publishing Limited. All rights reserved.


Employment opportunities | Partnering opportunities